BIOMAT Database Logo BIOMAT Database Logo

[Hyperkinetic supraventricular arrhythmias with associated depression of conductivity: therapeutic problems]. 1974

F Furlanello, and R Miori, and T Lanzetta, and M Disertori, and L Pangrazzi, and E Valentini, and L Zeni

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004554 Electric Countershock An electrical current applied to the HEART to terminate a CARDIAC ARRHYTHMIA. Cardiac Electroversion,Cardioversion,Defibrillation, Electric,Electroversion, Cardiac,Electrical Cardioversion,Electroversion Therapy,Therapy, Electroversion,Cardiac Electroversions,Cardioversion, Electrical,Cardioversions,Cardioversions, Electrical,Countershock, Electric,Countershocks, Electric,Defibrillations, Electric,Electric Countershocks,Electric Defibrillation,Electric Defibrillations,Electrical Cardioversions,Electroversion Therapies,Electroversions, Cardiac,Therapies, Electroversion
D005260 Female Females
D006329 Heart Conduction System An impulse-conducting system composed of modified cardiac muscle, having the power of spontaneous rhythmicity and conduction more highly developed than the rest of the heart. Conduction System, Heart,Conduction Systems, Heart,Heart Conduction Systems,System, Heart Conduction,Systems, Heart Conduction
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D000889 Anti-Arrhythmia Agents Agents used for the treatment or prevention of cardiac arrhythmias. They may affect the polarization-repolarization phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibers. Anti-arrhythmia agents are often classed into four main groups according to their mechanism of action: sodium channel blockade, beta-adrenergic blockade, repolarization prolongation, or calcium channel blockade. Anti-Arrhythmia Agent,Anti-Arrhythmia Drug,Anti-Arrhythmic,Antiarrhythmia Agent,Antiarrhythmia Drug,Antiarrhythmic Drug,Antifibrillatory Agent,Antifibrillatory Agents,Cardiac Depressant,Cardiac Depressants,Myocardial Depressant,Myocardial Depressants,Anti-Arrhythmia Drugs,Anti-Arrhythmics,Antiarrhythmia Agents,Antiarrhythmia Drugs,Antiarrhythmic Drugs,Agent, Anti-Arrhythmia,Agent, Antiarrhythmia,Agent, Antifibrillatory,Agents, Anti-Arrhythmia,Agents, Antiarrhythmia,Agents, Antifibrillatory,Anti Arrhythmia Agent,Anti Arrhythmia Agents,Anti Arrhythmia Drug,Anti Arrhythmia Drugs,Anti Arrhythmic,Anti Arrhythmics,Depressant, Cardiac,Depressant, Myocardial,Depressants, Cardiac,Depressants, Myocardial,Drug, Anti-Arrhythmia,Drug, Antiarrhythmia,Drug, Antiarrhythmic,Drugs, Anti-Arrhythmia,Drugs, Antiarrhythmia,Drugs, Antiarrhythmic
D001145 Arrhythmias, Cardiac Any disturbances of the normal rhythmic beating of the heart or MYOCARDIAL CONTRACTION. Cardiac arrhythmias can be classified by the abnormalities in HEART RATE, disorders of electrical impulse generation, or impulse conduction. Arrhythmia,Arrythmia,Cardiac Arrhythmia,Cardiac Arrhythmias,Cardiac Dysrhythmia,Arrhythmia, Cardiac,Dysrhythmia, Cardiac

Related Publications

F Furlanello, and R Miori, and T Lanzetta, and M Disertori, and L Pangrazzi, and E Valentini, and L Zeni
[Experience with intravenous amiodarone in hyperkinetic supraventricular arrhythmias].
January 1981, Giornale italiano di cardiologia,
F Furlanello, and R Miori, and T Lanzetta, and M Disertori, and L Pangrazzi, and E Valentini, and L Zeni
[Electrophysiologic evaluation of the supraventricular hyperkinetic arrhythmias].
January 1983, Giornale italiano di cardiologia,
F Furlanello, and R Miori, and T Lanzetta, and M Disertori, and L Pangrazzi, and E Valentini, and L Zeni
[Antiarrhythmic pacemaker in supraventricular and ventricular hyperkinetic arrhythmias].
January 1983, Giornale italiano di cardiologia,
F Furlanello, and R Miori, and T Lanzetta, and M Disertori, and L Pangrazzi, and E Valentini, and L Zeni
[Clinical experience with the efficacy of amiodarone in hyperkinetic supraventricular arrhythmias].
January 1981, Bollettino della Societa italiana di cardiologia,
F Furlanello, and R Miori, and T Lanzetta, and M Disertori, and L Pangrazzi, and E Valentini, and L Zeni
[Role of antitachycardia pacemakers in the treatment of supraventricular hyperkinetic arrhythmias].
August 1991, Cardiologia (Rome, Italy),
F Furlanello, and R Miori, and T Lanzetta, and M Disertori, and L Pangrazzi, and E Valentini, and L Zeni
[Experience with the treatment of supraventricular hyperkinetic arrhythmias by high-frequency atrial electrostimulation].
September 1982, Minerva cardioangiologica,
F Furlanello, and R Miori, and T Lanzetta, and M Disertori, and L Pangrazzi, and E Valentini, and L Zeni
[Problems of hyperkinetic arrhythmias in patients with prior myocardial infarct].
January 1979, Giornale italiano di cardiologia,
F Furlanello, and R Miori, and T Lanzetta, and M Disertori, and L Pangrazzi, and E Valentini, and L Zeni
[Supraventricular hyperkinetic arrhythmias in sick sinus syndrome. Clinical and electrophysiological evaluation].
January 1983, Giornale italiano di cardiologia,
F Furlanello, and R Miori, and T Lanzetta, and M Disertori, and L Pangrazzi, and E Valentini, and L Zeni
[Effectiveness of intravenous diltiazem in the treatment of supraventricular paroxysmal hyperkinetic arrhythmias].
September 1986, Cardiologia (Rome, Italy),
F Furlanello, and R Miori, and T Lanzetta, and M Disertori, and L Pangrazzi, and E Valentini, and L Zeni
[Intravenous amiodarone in supraventricular and ventricular hyperkinetic arrhythmias. Experience in 60 cases].
October 1983, Minerva cardioangiologica,
Copied contents to your clipboard!